Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CUDC-101

Inh 1012054-59-9 7-((4-((3-Ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide
Catalog No. ABIN7233246

Quick Overview for CUDC-101 (ABIN7233246)

Application

Inhibition (Inh)

Chemical Name

7-((4-((3-Ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide
  • Purpose

    Dual HDAC and EGFR inhibitor

    Characteristics

    A novel hybrid dual-acting HDAC and receptor tyrosine kinase inhibitor. It is a potent HDAC inhibitor which also inhibits EGFR and HER2, IC50 = 4.4, 2.4 and 15.7 nM respectively. It not only blocks EGFR and HER2 but also attenuates multiple compensatory pathways such as AKT, HER3 and MET which enable tumor cells to escape the effects of conventional EGFR/HER2 inhibitors.

    Purity

    >98 %

    Formula

    C24H26N4O4

    Solubility

    Soluble in DMSO (up to 25 mg/ml)
  • Restrictions

    For Research Use only
  • Format

    Powder

    Storage

    -20 °C
  • Background

    Epigenetics,Posttranslational modification,Kinase,Protein deacetylase,Cancer,Chromatin,AKT

    Molecular Weight

    434.49

    CAS-No

    1012054-59-9
You are here:
Chat with us!